electroCore to Participate at the Needham Virtual Healthcare Conference
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced its participation in the upcoming Needham Virtual Healthcare Conference on April 10, 2025.
CEO Dan Goldberger and CFO Joshua Lev will deliver a group presentation at 2:15 p.m. ET and engage in one-on-one meetings throughout the conference day. The presentation will be accessible via live audio webcast, with a replay option available.
Investors interested in meeting with management during the conference can arrange meetings through their Needham representative or by contacting FNK IR at ecor@fnkir.com.
electroCore (Nasdaq: ECOR), un'azienda di medicina bioelettronica e benessere in fase commerciale, ha annunciato la sua partecipazione alla prossima Needham Virtual Healthcare Conference che si terrà il 10 aprile 2025.
Il CEO Dan Goldberger e il CFO Joshua Lev terranno una presentazione di gruppo alle 14:15 ET e parteciperanno a incontri individuali durante la giornata della conferenza. La presentazione sarà accessibile tramite webcast audio dal vivo, con un'opzione di replay disponibile.
Gli investitori interessati a incontrare la direzione durante la conferenza possono organizzare incontri tramite il loro rappresentante Needham o contattando FNK IR all'indirizzo ecor@fnkir.com.
electroCore (Nasdaq: ECOR), una empresa de medicina bioelectrónica y bienestar en etapa comercial, ha anunciado su participación en la próxima Needham Virtual Healthcare Conference el 10 de abril de 2025.
El CEO Dan Goldberger y el CFO Joshua Lev realizarán una presentación grupal a las 2:15 p.m. ET y participarán en reuniones uno a uno a lo largo del día de la conferencia. La presentación será accesible a través de una transmisión de audio en vivo, con una opción de repetición disponible.
Los inversores interesados en reunirse con la dirección durante la conferencia pueden organizar reuniones a través de su representante de Needham o contactando a FNK IR en ecor@fnkir.com.
electroCore (Nasdaq: ECOR), 상업 단계의 생체 전자 의학 및 웰니스 회사가 2025년 4월 10일에 열리는 Needham Virtual Healthcare Conference에 참가한다고 발표했습니다.
CEO Dan Goldberger와 CFO Joshua Lev는 오후 2시 15분 ET에 그룹 발표를 진행하고 회의 기간 동안 일대일 미팅에 참여할 예정입니다. 발표는 실시간 오디오 웹캐스트를 통해 접근 가능하며, 다시 보기 옵션도 제공됩니다.
회의 중 경영진과의 미팅을 원하는 투자자는 Needham 대표를 통해 미팅을 조정하거나 FNK IR에 ecor@fnkir.com으로 연락하여 미팅을 요청할 수 있습니다.
electroCore (Nasdaq: ECOR), une entreprise de médecine bioélectronique et de bien-être en phase commerciale, a annoncé sa participation à la prochaine Needham Virtual Healthcare Conference qui se tiendra le 10 avril 2025.
Le PDG Dan Goldberger et le CFO Joshua Lev présenteront un exposé de groupe à 14h15 ET et participeront à des réunions individuelles tout au long de la journée de la conférence. La présentation sera accessible par diffusion audio en direct, avec une option de rediffusion disponible.
Les investisseurs intéressés à rencontrer la direction pendant la conférence peuvent organiser des réunions par l'intermédiaire de leur représentant Needham ou en contactant FNK IR à l'adresse ecor@fnkir.com.
electroCore (Nasdaq: ECOR), ein Unternehmen für bioelektronische Medizin und Wellness in der kommerziellen Phase, hat seine Teilnahme an der bevorstehenden Needham Virtual Healthcare Conference am 10. April 2025 angekündigt.
CEO Dan Goldberger und CFO Joshua Lev werden um 14:15 Uhr ET eine Gruppenpräsentation halten und während des Konferenztags an Einzelgesprächen teilnehmen. Die Präsentation wird über einen Live-Audio-Webcast zugänglich sein, mit einer verfügbaren Wiederholungsoption.
Investoren, die während der Konferenz ein Treffen mit dem Management wünschen, können Meetings über ihren Needham-Vertreter oder durch Kontaktaufnahme mit FNK IR unter ecor@fnkir.com arrangieren.
- None.
- None.
ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place virtually on April 10, 2025.
Dan Goldberger, CEO and Joshua Lev, Chief Financial Officer, will host a group presentation at 2:15 p.m. ET and participate in one-on-one meetings throughout the day.
DATE: April 10, 2025
TIME: 2:15 p.m. ET
WEBCAST: electroCore Group Presentation
A live audio webcast and replay of the presentation will be available using the above dedicated link. Investors attending the conference who are interested in scheduling a meeting with management can do so by contacting their Needham representative, or by emailing FNK IR at ecor@fnkir.com for more information.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
When is electroCore (ECOR) presenting at the Needham Virtual Healthcare Conference 2025?
How can investors attend electroCore's (ECOR) presentation at the Needham Conference?
Who will represent electroCore (ECOR) at the 2025 Needham Virtual Healthcare Conference?
How can investors schedule one-on-one meetings with electroCore (ECOR) management?
